Resmed Inc (NYSE:RMD)
| 160.90 BATS BZX Real-Time Price As of 9:33am ET |  +1.26 / +0.79%Today’s Change | 132.24 Today|||52-Week Range 243.52 | -22.69% Year-to-Date |
Latest RMD News | Press Releases
| Envista (NVST) Up 6.8% Since Last Earnings Report: Can It Continue? Dec 01 / Zacks.com - Paid Partner Content | Insider Sell: CFO Brett Sandercock Sells 3,000 Shares of ResMed Inc (RMD) Nov 30 / GuruFocus News - Paid Partner Content |
| Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick Dec 01 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 159.64 |
| Today’s open | 159.64 |
| Day’s range | 159.64 - 161.28 |
| Volume | 896 |
| Average volume (3 months) | 1,604,350 |
| Market cap | $23.5B |
Data as of 9:33am ET, 12/04/2023
Growth & Valuation
| Earnings growth (last year) | +14.61% |
| Earnings growth (this year) | +14.82% |
| Earnings growth (next 5 years) | +9.00% |
| Revenue growth (last year) | +18.02% |
| P/E ratio | 26.0 |
| Price/Sales | 7.63 |
| Price/Book | 5.68 |
Competitors
Data as of 9:33am ET, 12/04/2023
Financials
| Next reporting date | January 25, 2024 |
| EPS forecast (this quarter) | $1.81 |
| Annual revenue (last year) | $4.2B |
| Annual profit (last year) | $897.6M |
| Net profit margin | 21.25% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
